Jackson Square Partners’s Tandem Diabetes Care TNDM Stock Holding History

Jackson Square Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,499,740	Closed	-$174M	–	100
2022 Q1	$174M	Sell	1,499,740 -1,004,606	-40%	-$117M	1.73%	18
2021 Q4	$377M	Sell	2,504,346 -1,067,292	-30%	-$144M	3.17%	4
2021 Q3	$426M	Sell	3,571,638 -51,456	-1%	-$5.67M	2.7%	5
2021 Q2	$353M	Sell	3,623,094 -82,718	-2%	-$7.38M	2.02%	15
2021 Q1	$327M	Buy	3,705,812 +518,825	+16%	+$48.2M	1.86%	16
2020 Q4	$305M	Buy	+3,186,987	New	+$328M	1.22%	35

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Jackson Square Partners's TNDM Position: Q2 2022 in Review

Jackson Square Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 1,499,740 shares — an estimated $174M sold.

Jackson Square Partners first reported a position in TNDM in Q4 2020 and held it in 6 quarters. The position peaked at $426M in Q3 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

Jackson Square Partners reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
Jackson Square Partners sold 1,499,740 Tandem Diabetes Care shares in Q2 2022, an estimated $174M.
Jackson Square Partners first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 6 quarters.
Jackson Square Partners's Tandem Diabetes Care position peaked at $426M in Q3 2021.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Jackson Square Partners's 13F filing for Q2 2022, filed 12 Aug 2022.